Merck Wins Hepatitis C Drug Patent Claim Against Gilead
Wednesday, March 23, 2016 - 18:00
in Mathematics & Economics
A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.